摘要
随着人们对凋亡机制认识的加深 ,胱冬酶 (caspase)抑制剂在脑缺血中的临床价值也引起广泛关注。胱冬酶抑制剂能阻断凋亡所需的特异性蛋白酶 ,而不会产生绝大多数广谱药物的不良反应 ,且治疗窗较其他神经保护药宽。因此 ,研究胱冬酶抑制剂的前景诱人。
With the recognition of the mechanisms of apoptosis, the clinical value of caspase inhibitor in cerebral ischemia has aroused general concern. Caspase inhibitor can block the specific protease that apoptosis needs, and it cannot develop the adverse effects like most broad-spectrum drugs. In comparison with other neuroprotective agents, caspase inhibitor has a broader therapeutic window. Therefore, the prospect of research into the caspase inhibitor is attractive.
出处
《国外医学(脑血管疾病分册)》
2004年第7期544-547,共4页
Foreign Medical Sciences Cerebrovascular Diseases